Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "V09" (95)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
What is an ATC-Code?
ATC-Overview
Diagnostic Radiopharmaceuticals (V09) 10 products
WHO-DDD
IP
Netspot 40 mcg
PR
PR
k.A.
kit for radiopharmaceutical preparation: Oxodotreotidum 40 µg
Kit für ein radioaktives Arzneimittel: Oxodotreotidum 40 µg
Novartis Pharma
Schweiz AG
A
FB
G
Elutec Tc-99m Generator
Gerät
PR
PR
10 %
Heider AG
A / SL
FB
G
Elutec Tc-99m Generator
Gerät
PR
PR
10 %
Heider AG
A / SL
FB
G
Elutec Tc-99m Generator
Gerät
PR
PR
10 %
Heider AG
A / SL
FB
G
Elutec Tc-99m Generator
Gerät
PR
PR
10 %
Heider AG
A / SL
FB
G
Elutec Tc-99m Generator
Gerät
PR
PR
10 %
Heider AG
A / SL
FB
G
Elutec Tc-99m Generator
Gerät
PR
PR
10 %
Heider AG
A / SL
FB
G
Elutec Tc-99m Generator
Gerät
PR
PR
10 %
Heider AG
A / SL
FB
G
Elutec Tc-99m Generator
Gerät
PR
PR
10 %
Heider AG
A / SL
FB
G
Renocis
5 Flasche(n)
PR
260.00
k.A.
Marker kit: 2 Active Agents
Schering (Schweiz) AG
A
FB
G
Iodine Ioflupane (123i) (V09AB03) 2 products
WHO-DDD
DrugBank.ca
L
IP
DaTSCAN TM 123 I-
Ioflupane (INN)
2.5 ml
936.61
1084.05
10 %
Injection solution: Ioflupanum(123-I) zum Kalibrierungszeitpunkt 185MBq / 2.5ml
GE Healthcare AG
A / SL / SO
FB
G
L
IP
Striascan 74 MBq/ml
749.29
891.85
10 %
Injection solution: Ioflupanum(123-I) zum Kalibrierungszeitpunkt 185MBq / 2.5ml
b.e.imaging.ag
A / SL / SG
FB
G
Flutemetamol (18f) (V09AX04) 2 products
WHO-DDD
DrugBank.ca
IP
Vizamyl 150MBq/ml
10 ml
PR
PR
k.A.
Injection solution: Flutemetamolum(18-f) 150 MBq/ml
GE Healthcare AG
A
FB
G
IP
Vizamyl 150MBq/ml
15 ml
PR
PR
k.A.
Injection solution: Flutemetamolum(18-f) 150 MBq/ml
GE Healthcare AG
A
FB
G
Florbetaben (18f) (V09AX06) 1 products
WHO-DDD
DrugBank.ca
IP
Neuraceq 300 MBq/ml
PR
PR
k.A.
Injection solution: Florbetabenum(18-f) 300 MBq/ml
SWAN Isotopen AG SWAN
Haus, Inselspital
A
FB
G
Technetium (99mtc) Oxidronic Acid (V09BA01) 1 products
WHO-DDD
DrugBank.ca
IP
TechneScan HDP
5 Flasche(n)
PR
142.10
10 %
Marker kit: Dinatrii Oxidronas 3 mg
b.e.imaging.ag
A / SL
FB
G
Technetium (99mtc) Butedronic Acid (V09BA04) 1 products
WHO-DDD
DrugBank.ca
IP
Teceos
5 x 14.2 mg
PR
142.00
10 %
Marker kit: Tetranatrii Butedronas 13 mg
b.e.imaging.ag
A / SL
FB
G
Technetium (99mtc) Pentetic Acid (V09CA01) 1 products
WHO-DDD
DrugBank.ca
IP
TechneScan DTPA
5 Flasche(n)
PR
145.00
10 %
Marker kit: Acidum Penteticum 20.8 mg
b.e.imaging.ag
A / SL
FB
G
Technetium (99mtc) Succimer (V09CA02) 1 products
WHO-DDD
DrugBank.ca
IP
TechneScan DMSA
5
PR
234.00
10 %
Marker kit: Succimerum 1.2 mg
b.e.imaging.ag
A / SL
FB
G
Technetium (99mtc) Mertiatide (V09CA03) 3 products
WHO-DDD
DrugBank.ca
IP
MAG-3 Kit
5 Durchstechflasche(n)
PR
502.15
10 %
Marker kit: Mertiatidum
medeo AG
A / SL
FB
G
IP
TechneScan MAG3
5 Flasche(n)
PR
619.50
10 %
Tc-: Betiatidum 1 mg
b.e.imaging.ag
A / SL
FB
G
Renoscint (MAG3) 1.0mg
6
PR
PR
k.A.
Marker kit: Betiatidum 1 mg
Solumedics AG
A
FB
G
Technetium (99mtc) Nanocolloid (V09DB01) 1 products
WHO-DDD
DrugBank.ca
IP
NanoHSA-ROTOP 0.5
5
PR
PR
k.A.
Marker kit: Albuminum Humanum Colloidale
medeo AG
A
FB
G
Technetium (99mtc) Technegas (V09EA02) 1 products
WHO-DDD
DrugBank.ca
IP
Tetley Technegas
50 piece(s)
3470.94
3791.25
10 %
Generator: Graphites 1.34 g
medeo AG
A / SL
FB
G
Technetium (99mtc) Pertechnetate (V09FX01) 14 products
WHO-DDD
DrugBank.ca
IP
UltratechneKow FM
2.15 GBq
PR
PR
10 %
Generator: Molybdenum(99-mo) zum Kalibrierungszeitpunkt 2.15-43 G
b.e.imaging.ag
A / SL
FB
G
IP
UltratechneKow FM
4.3 GBq
PR
PR
10 %
Generator: Molybdenum(99-mo) zum Kalibrierungszeitpunkt 2.15-43 G
b.e.imaging.ag
A / SL
FB
G
IP
UltratechneKow FM
6.45 GBq
PR
PR
10 %
Generator: Molybdenum(99-mo) zum Kalibrierungszeitpunkt 2.15-43 G
b.e.imaging.ag
A / SL
FB
G
IP
UltratechneKow FM
8.6 GBq
PR
PR
10 %
Generator: Molybdenum(99-mo) zum Kalibrierungszeitpunkt 2.15-43 G
b.e.imaging.ag
A / SL
FB
G
IP
UltratechneKow FM
10.75 GBq
PR
PR
10 %
Generator: Molybdenum(99-mo) zum Kalibrierungszeitpunkt 2.15-43 G
b.e.imaging.ag
A / SL
FB
G
IP
UltratechneKow FM
12.9 GBq
PR
PR
10 %
Generator: Molybdenum(99-mo) zum Kalibrierungszeitpunkt 2.15-43 G
b.e.imaging.ag
A / SL
FB
G
IP
UltratechneKow FM
17.2 GBq
PR
PR
10 %
Generator: Molybdenum(99-mo) zum Kalibrierungszeitpunkt 2.15-43 G
b.e.imaging.ag
A / SL
FB
G
IP
UltratechneKow FM
21.5 GBq
PR
PR
10 %
Generator: Molybdenum(99-mo) zum Kalibrierungszeitpunkt 2.15-43 G
b.e.imaging.ag
A / SL
FB
G
IP
UltratechneKow FM
25.8 GBq
PR
PR
10 %
Generator: Molybdenum(99-mo) zum Kalibrierungszeitpunkt 2.15-43 G
b.e.imaging.ag
A / SL
FB
G
IP
UltratechneKow FM
30.1 GBq
PR
PR
10 %
Generator: Molybdenum(99-mo) zum Kalibrierungszeitpunkt 2.15-43 G
b.e.imaging.ag
A / SL
FB
G
IP
UltratechneKow FM
34.4 GBq
PR
PR
10 %
Generator: Molybdenum(99-mo) zum Kalibrierungszeitpunkt 2.15-43 G
b.e.imaging.ag
A / SL
FB
G
IP
UltratechneKow FM
43 GBq
PR
PR
10 %
Generator: Molybdenum(99-mo) zum Kalibrierungszeitpunkt 2.15-43 G
b.e.imaging.ag
A / SL
FB
G
IP
Pertector 2.3-57.1 GBq
Gerät
PR
PR
10 %
medeo AG
A / SL
FB
G
IP
Tekcis
Gerät
PR
PR
10 %
Tc-: Molybdenum(99-mo) zum Kalibrierungszeitpunkt 2.4-60 G
b.e.imaging.ag
A / SL
FB
G
Sodium Iodide (123i) (V09FX02) 6 products
WHO-DDD
DrugBank.ca
IP
Natriumiodid (I-123)
PR
240.20
10 %
Injection solution: Natrii Iodidum(123-I) zum Kalibrierungszeitpunkt 37 MBq/ml
medeo AG
A / SL
FB
G
IP
Sodium iodide (I-123)
injection Curium
1 ml
PR
266.25
10 %
Injection solution: Natrii Iodidum(123-i) 37 MBq/ml
b.e.imaging.ag
A / SL
FB
G
IP
Sodium iodide (I-123)
injection Curium
2 ml
PR
389.10
10 %
Injection solution: Natrii Iodidum(123-i) 37 MBq/ml
b.e.imaging.ag
A / SL
FB
G
IP
Sodium iodide (I-123)
injection Curium
5 ml
PR
737.25
10 %
Injection solution: Natrii Iodidum(123-i) 37 MBq/ml
b.e.imaging.ag
A / SL
FB
G
IP
Sodium iodide (I-123)
injection Curium
10 ml
PR
962.50
10 %
Injection solution: Natrii Iodidum(123-i) 37 MBq/ml
b.e.imaging.ag
A / SL
FB
G
IP
Natriumiodid (I-123)
PR
230.20
10 %
Diagnosekapseln: Natrii Iodidum(123-I) zum Kalibrierungszeitpunkt 7.4 MBq
medeo AG
A / SL
FB
G
Technetium (99mtc) Sestamibi (V09GA01) 2 products
WHO-DDD
DrugBank.ca
L
IP
TechneScan Sestamibi
5 Flasche(n)
1547.94
1699.90
10 %
Lyophilisat for injection: Tetrakis(2-methoxyisobutylisonitril)cupri(i) Tetrafluoroboras 1 mg
b.e.imaging.ag
A / SL / SG
FB
G
L
IP
Stamicis
5 Flasche(n)
1547.94
1699.90
10 %
Marker kit: Tetrakis(2-methoxyisobutylisonitril)cupri(i) Tetrafluoroboras 1 mg
b.e.imaging.ag
A / SL / SG
FB
G
Technetium (99mtc) Tetrofosmin (V09GA02) 1 products
WHO-DDD
DrugBank.ca
L
IP
Myoview
5 Flasche(n)
1518.64
1668.05
10 %
Marker kit: Tetrofosminum
GE Healthcare AG
A / SL
FB
G
Thallium (201tl) Chloride (V09GX01) 3 products
WHO-DDD
DrugBank.ca
L
IP
Thallous chloride (TI-
201) injection Curium
85 MBq
PR
255.00
10 %
Injection solution: Thallosi(201-Tl) Chloridum zum Kalibrierungszeitpunkt 37 MBq/ml
b.e.imaging.ag
A / SL
FB
G
L
IP
Thallous chloride (TI-
201) injection Curium
213 MBq
PR
509.95
10 %
Injection solution: Thallosi(201-Tl) Chloridum zum Kalibrierungszeitpunkt 37 MBq/ml
b.e.imaging.ag
A / SL
FB
G
L
IP
Thallous chloride (TI-
201) injection Curium
370 MBq
PR
788.50
10 %
Injection solution: Thallosi(201-Tl) Chloridum zum Kalibrierungszeitpunkt 37 MBq/ml
b.e.imaging.ag
A / SL
FB
G
Rubidium (82rb) Chloride (V09GX04) 2 products
WHO-DDD
DrugBank.ca
IP
Cardiogen-82
PR
PR
k.A.
generatore di radionuclidi: Strontium (82-sr) la Calibrazione Data 3.3-5.6 G
Bracco Suisse SA
A
FB
G
IP
Ruby-Fill (Rubidium Rb-82
Generator) 3.7 GBq
Gerät
PR
PR
k.A.
medeo AG
A
FB
G
Technetium (99mtc) Antigranulocyte Antibody (V09HA03) 1 products
WHO-DDD
DrugBank.ca
IP
Scintimun
2
PR
PR
k.A.
Marker kit: Besilesomabum 1 mg
b.e.imaging.ag
A
FB
G
Technetium (99mtc) Hynic-Octreotide (V09IA07) 1 products
WHO-DDD
DrugBank.ca
IP
Tektrotyd
2
PR
1158.60
10 %
Marker kit: Acidum Ethylendiamini-N,n'-Diaceticum 10 mg
medeo AG
A / SL
FB
G
Indium (111in) Compounds (V09IB) 5 products
WHO-DDD
IP
Indium (In-111) Chloride
Solution Curium 370
MBq/ml
0.3 ml
PR
PR
k.A.
Injection solution: Indii(111-in) Trichloridum 370 MBq/ml
b.e.imaging.ag
A
FB
G
IP
Indium (In-111) Chloride
Solution Curium 370
MBq/ml
0.5 ml
PR
PR
k.A.
Injection solution: Indii(111-in) Trichloridum 370 MBq/ml
b.e.imaging.ag
A
FB
G
IP
Indium (In-111) Chloride
Solution Curium 370
MBq/ml
1 ml
PR
PR
k.A.
Injection solution: Indii(111-in) Trichloridum 370 MBq/ml
b.e.imaging.ag
A
FB
G
IP
Indium (In-111) Chloride
Solution Curium 370
MBq/ml
1.5 ml
PR
PR
k.A.
Injection solution: Indii(111-in) Trichloridum 370 MBq/ml
b.e.imaging.ag
A
FB
G
IP
Indium (In-111) Chloride
Solution Curium 370
MBq/ml
2 ml
PR
PR
k.A.
Injection solution: Indii(111-in) Trichloridum 370 MBq/ml
b.e.imaging.ag
A
FB
G
Indium (111in) Pentetreotide (V09IB01) 1 products
WHO-DDD
DrugBank.ca
IP
OctreoScan
2 Flasche(n)
PR
1134.40
10 %
Kit: Pentetreotidum 10 µg
Kit: Indii(111-In) Trichloridum zum Kalibrierungszeitpunkt 122MBq / 1.1ml
b.e.imaging.ag
A / SL
FB
G
Iobenguane (123i) (V09IX01) 18 products
WHO-DDD
DrugBank.ca
IP
MIBG (I-123) injection
Curium
1 ml
PR
494.90
10 %
b.e.imaging.ag
A / SL
FB
G
IP
MIBG (I-123) injection
Curium
2 ml
PR
797.70
10 %
b.e.imaging.ag
A / SL
FB
G
IP
MIBG (I-123) injection
Curium
3 ml
PR
1075.75
10 %
b.e.imaging.ag
A / SL
FB
G
IP
MIBG (I-123) injection
Curium
5 ml
PR
1622.65
10 %
b.e.imaging.ag
A / SL
FB
G
IP
AdreView
37 MBq
PR
335.30
10 %
medeo AG
A / SL
FB
G
IP
MIBG (I-123) injection
Curium
4 ml
PR
PR
k.A.
b.e.imaging.ag
A
FB
G
IP
AdreView
74 MBq
PR
PR
k.A.
medeo AG
A
FB
G
IP
AdreView
111 MBq
PR
PR
k.A.
medeo AG
A
FB
G
IP
AdreView
148 MBq
PR
PR
k.A.
medeo AG
A
FB
G
IP
AdreView
185 MBq
PR
PR
k.A.
medeo AG
A
FB
G
IP
AdreView
222 MBq
PR
PR
k.A.
medeo AG
A
FB
G
IP
AdreView
259 MBq
PR
PR
k.A.
medeo AG
A
FB
G
IP
AdreView
296 MBq
PR
PR
k.A.
medeo AG
A
FB
G
IP
AdreView
333 MBq
PR
PR
k.A.
medeo AG
A
FB
G
IP
AdreView
370 MBq
PR
PR
k.A.
medeo AG
A
FB
G
IP
AdreView
407 MBq
PR
PR
k.A.
medeo AG
A
FB
G
IP
AdreView
444 MBq
PR
PR
k.A.
medeo AG
A
FB
G
IP
AdreView
481 MBq
PR
PR
k.A.
medeo AG
A
FB
G
Fludeoxyglucose (18f) (V09IX04) 5 products
WHO-DDD
DrugBank.ca
IP
18F-FDG-FR
15 ml
PR
PR
k.A.
Injection solution: Fludeoxyglucosum(18-f) Zum Kalibrierungszeitpunkt 500-5000 MBq/ml
Posimed Radiopharm AG
A
FB
G
IP
Flu-SWAN
15 ml
PR
PR
k.A.
Injection solution: Fludeoxyglucosum(18-f) Zum Kalibrierungszeitpunkt 185 MBq/ml
SWAN Isotopen AG SWAN
Haus, Inselspital
A
FB
G
IP
Glupet
Durchstechflasche(n) à 10 ml
PR
PR
k.A.
Les hôpitaux
universitaires de
Genève
A
FB
G
IP
18F-Fluoroglukose ZRP 0.5 - 5
GBq/ml
Durchstechflasche(n)
PR
PR
k.A.
Injektionslösung zur i.v. Applikation: Fludeoxyglucosum(18-f) 500-5000 MBq/ml
Universitätsspital
Zürich
A
FB
G
IP
Gluscan
/ 10 ml
PR
PR
k.A.
solution injectable multidoses: 2 Active Agents
ADVANCED ACCELERATOR
APPLICATIONS
INTERNATIONAL SA
A
FB
G
Fluorodopa (18f) (V09IX05) 1 products
WHO-DDD
DrugBank.ca
IP
Dopaview 222 MBq/ml
1 ml
PR
PR
k.A.
Injection solution: Fluorodopum(18-f) au Moment de la Calibration 222 MBq/ml
ADVANCED ACCELERATOR
APPLICATIONS
INTERNATIONAL SA
A
FB
G
Sodium Fluoride (18f) (V09IX06) 1 products
WHO-DDD
DrugBank.ca
IP
Natriumfluorid (18F) ZRP
ampoule(s)
PR
PR
k.A.
Injection solution: Natrii Fluoridum(18-f) 0.02-8 G/ml
Universitätsspital
Zürich
A
FB
G
Fluorocholine (18f) (V09IX07) 3 products
WHO-DDD
DrugBank.ca
IP
AAACholine 222 MBq/ml
1 ml
PR
PR
k.A.
Injection solution: Fluorocholini(18-f) Chloridum au Moment de Remplissage 222 MBq/ml
ADVANCED ACCELERATOR
APPLICATIONS
INTERNATIONAL SA
A
FB
G
IP
SWAN-Cholin 222 MBq/ml
222 MBq
PR
PR
k.A.
Injection solution: Fluorocholinum(18-f) 222 MBq/ml
SWAN Isotopen AG SWAN
Haus, Inselspital
A
FB
G
IP
18F-Fluorocholine ZRP
Durchstechflasche(n)
PR
PR
k.A.
Injektionslösung zur i.v. Applikation: Fluorocholinum(18-f) zum Zeitpunkt der Abfüllung 0.02-4 G/ml
Universitätsspital
Zürich
A
FB
G
Fluoroethyl-L-Tyrosine (18f) (V09IX10) 1 products
WHO-DDD
DrugBank.ca
IP
18F-Fluoroethyltyrosine ZRP
0.05-3.5 GBq/ml
PR
PR
k.A.
Injektionslösung zur IV Applikation: Fluoroethyltyrosinum(18-f) zum Zeitpunkt der Abfüllung 50-3500 MBq/ml
Universitätsspital
Zürich
A
FB
G
Gallium (68ga) Gozetotide (V09IX14) 1 products
WHO-DDD
IP
Locametz 25 ug
PR
PR
k.A.
trousse pour préparation radiopharmaceutique: Gozetotidum 25 µg
Novartis Pharma
Schweiz AG
A
FB
G
Piflufolastat (18f) (V09IX16) 2 products
WHO-DDD
Pylclari 1000 MBq/ml
1 ml
PR
PR
k.A.
Injection solution: Piflufolastatum(18-f) 1000 MBq/ml
b.e.imaging.ag
A
FB
G
Pylclari 1500 MBq/ml
1 ml
PR
PR
k.A.
Injection solution: Piflufolastatum(18-f) 1500 MBq/ml
b.e.imaging.ag
A
FB
G
Psma-1007 (18f) (V09IX17) 3 products
WHO-DDD
18F-PSMA-1007 ZRP ≥ 40 MBq / mL
PR
PR
k.A.
Universitätsspital
Zürich
A
FB
G
Radelumin 200 - 4500
MBq/ml
15 ml
PR
PR
k.A.
Posimed Radiopharm AG
A
FB
G
IP
SWAN-PSMA-1007 1 ml / 10 ml
15 ml
PR
PR
k.A.
SWAN Isotopen AG SWAN
Haus, Inselspital
A
FB
G
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home